NEJM CARDIOVASCULAR DISEASE ARTICLES - Part 3 pot
... animal model of venous hy- pertension: the role of inflammation in 33 . 34 . 35 . 36 . 37 . 38 . 39 . 40. 41. 42. 43. 44. 45. venous valve failure. J Vasc Surg 2005;41: 30 3- 1 1. Ta ka s e S, L er on ... disability 533 /1542 (34 .6) 100 /38 1 (26.2) Moderate disability 638 /1542 (41.4) 164 /38 1 ( 43. 0) Severe disability 34 2/1542 (22.2) 1 03/ 381 (27.0) Coma or vegetative state...
Ngày tải lên: 14/08/2014, 07:20
... F Enon 1st 2nd 3rd Manson 1 of 1 0 6-2 1-0 7 ARTIST: ts 35 625 ISSUE: 0.65 0.41 1. 53 1.67 1.89 3. 08 1 .38 1.60 1 .37 1.85 2.04 4.18 43 35 32 34 40 53 34 45 36 53 38 56 37 42 41 29 34 44 47 23 17 14 17 20 29 16 25 17 30 19 39 16 24 24 13 18 22 21 ≥10 ... (%) 0. 23 No 152/ 537 (28 .3) 167/527 (31 .7) Yes 38 5/ 537 (71.7) 36 0/527 (68 .3) Moderate-to-severe...
Ngày tải lên: 14/08/2014, 07:20
... 0.56 Body-mass index† 28 3 27±4 27±4 0 .37 NYHA class — no. (%) 0 .34 1 7 (30 ) 7 (21) 5 (14) 2 11 (48) 13 (38 ) 18 (51) 3 5 (22) 12 (35 ) 12 (34 ) 4 0 2 (6) 0 Serum creatinine — mg/dl‡ 1.1±0 .3 1.1±0.2 1.1±0.4 ... 2002;288 :32 1 -3 3. Nissen SE, Tardif JC, Nicholls SJ, et al. Effect of torcetrapib on the progression of coronary atherosclerosis. N Engl J Med 2007 ;35 6: 130 4-1...
Ngày tải lên: 14/08/2014, 07:20
NEJM CARDIOVASCULAR DISEASE ARTICLES - Part 2 pdf
... II RAVEL SCANDSTENT SCORPIUS SESAMI SIRIUS STRATEGY TYPHOON Overall 32 /264 5/50 8/54 10/80 26/175 59/250 6/100 20/120 7/1 63 15/95 11/160 91/ 533 17/87 24 /35 5 33 1/2486 41/281 14/50 11/29 33 /80 58/177 73/ 250 25/100 28/118 51/159 32 /98 26/160 164/525 31 /88 ... F Enon 1st 2nd 3rd Kastrati 5 of 5 0 3- 0 8-0 7 ARTIST: ts 35 610 A B No. at Risk Sirolimus stent Bare-metal...
Ngày tải lên: 14/08/2014, 07:20
NEJM CARDIOVASCULAR DISEASE ARTICLES - Part 6 ppsx
... for treatment of femoropop- liteal arterial disease: meta-analysis. Ra- diology 2001;221: 13 7-4 5. 25. 26. 27. 28. 29. 30 . 31 . 32 . 33 . 34 . 35 . 36 . Downloaded from www .nejm. org on February 18, 2008 ... 51.56 (36 .90 to 66. 23) 0.24 Percent change 14 .37 31 .14 3. 46±19.02 10.9 (−7.7 to 29.5) 0.24 5.97 (−27 .32 to 39 .26) 2.71 ( 37 .75 to 43. 16) 0.82 Infarct size at 6 mo...
Ngày tải lên: 14/08/2014, 07:20
NEJM CARDIOVASCULAR DISEASE ARTICLES - Part 8 pps
... 0.72 1 36 1 (31 ) 34 3 (30 ) 2 446 (39 ) 439 (39 ) 3 341 (30 ) 35 5 (31 ) Disease in graft¶ 77 (62) 85 (69) 0 .36 Proximal LAD disease 36 0 (31 ) 417 (37 ) 0.01 Ejection fraction 60.8±11.2 60.9±10 .3 0.86 * ... 100 0 100 0 1-Vessel disease 0 33 0 18 2-Vessel disease 0 30 0 24 3- Vessel disease 0 26 0 45 Left main coronary artery disease 0 11 0 13 NT-pro-BNP (pg/ml) 0....
Ngày tải lên: 14/08/2014, 07:20
NEJM CARDIOVASCULAR DISEASE ARTICLES - Part 9 ppsx
... 187.2 (122.1 to 239 .1) 179.1±79.4 166.6 (122.4 to 226.6) 0.26 Percent 38 .9±11.0 38 .9 (32 .2 to 46.2) 39 .5±10.8 40.0 (32 .5 to 46 .3) 38 .4±11 .3 38.2 (31 .7 to 45.8) 0.18 18-Mo follow-up Total (mm 3 ) 191.7±110.7 ... 40.2±10.5 39 .9 (33 .8 to 47.1) 41.4±10.0 41.8 (35 .0 to 47.7) 39 .0±10.8 38 .7 (31 .6 to 45.7) <0.001 Change from baseline Total (mm 3 ) 2 ....
Ngày tải lên: 14/08/2014, 07:20